Top Biotech Companies in Denver & Boulder, CO (64)
Founded in 2009, Flagship Biosciences, Inc., is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available. We are revolutionizing biomarker analysis to improve drug development and diagnostics using the power of AI with a consultative approach. Our services and technology dramatically improve on the data and interpretation from traditional methods, eliminating variability associated...
MBio Diagnostics is now LightDeck Diagnostics! LightDeck Diagnostics believes in a new approach to healthcare, where fast, accurate, simple, low-cost diagnostic tests will be run wherever and whenever they are needed, without compromise. The company’s proprietary LightDeck® platform combines an advanced laser waveguide with novel materials and patented manufacturing techniques to deliver lab-quality results anywhere, in minutes. LightDeck is introducing a...
In a rapidly changing industry, caregivers remain the constant. Every day they demonstrate their passion for helping people despite unprecedented pressure to increase access and quality of care with the same or fewer resources. Hillrom is driven by patient-centered care. Everything we do, and all our products and technologies, are designed to enhance outcomes for patients and caregivers. It starts...
GT Molecular was created to develop new molecular detection technology for cancer research and harmful pathogen detection. We have recently focused these powerful tools on the detection of SARS-CoV-2 in wastewater to support communities around the country with their monitoring programs. Ultrasensitive Molecular Assays, Digital PCR and qPCR Tests End-to-End solutions for cancer detection and waterborne pathogens including SARS-CoV-2. Detect as...
Folium Biosciences is the largest, fully and vertically integrated producer of phytocannabinoid-rich (PCR) hemp oil in the world. We are a premier bulk supplier of highly refined PCR hemp oil that can then be used for a multitude of consumer and pharmaceutical product applications.
We believe in the power of technology to improve lives, from new opportunities and mission-critical functionality to user experience. Our team is proud to partner with passionate companies focused on reducing energy consumption, curing disease, improving education, building smart cities, and more – and with leading Cloud providers, including Amazon Web Services (AWS) and Microsoft Azure.
Horizon Ag-Products, LLC is a science and research-driven producer of innovative, naturally-derived plant health solutions for the global agricultural market. The company specializes in increasing nutrient uptake efficiency to improve fertilizer performance and maximize crop quality and yields. Its mission is to enable sustainable farming and environmental stewardship worldwide by providing scientifically-proven, naturally-derived products.
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
Asimov's Top Stability & Growth Strengths
Strategic Partnerships: Meaningful partnerships with blue‑chip players (e.g., Cytiva, LOTTE Biologics, Novo Nordisk, AGC Biologics) signal third‑party validation and channels for broader adoption of its platform.
Product Line Growth: Product launches and updates across CHO Edge, LV Edge, and AAV Edge (including stable AAV producer cell lines and CHO Edge Rapid Pools) indicate an expanding offering aimed at biologics and gene therapy workflows.
Investor Backing & Capital Strength: Raising over $200M provides financial runway to scale R&D and commercialization and supports continued platform build‑out through 2024–2026.
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with...
Stryker's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double-digit annual sales expansion through 2025, with management guiding to continued organic growth into 2026.
Strong Market Position & Advantage: Evidence highlights leadership in orthopedic robotics and top-tier standings among global medtech peers, with notable share in joint replacement and integrated OR technologies.
Diversified Revenue Streams: Multiple segments and recent vascular-focused acquisitions broaden growth drivers and reduce reliance on any single category.
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers...
Bio-Techne's Top Stability & Growth Strengths
Profitability: Adjusted EPS and operating margins expanded despite muted top-line trends, including a 31.1% adjusted operating margin in the most recent quarter. Cost and productivity actions supported margin improvement even as sales were flat year over year.
Strong Market Position & Advantage: Leadership in niches such as immunoassays and high-quality proteins (R&D Systems), RNA-ISH (RNAscope), and automated protein analysis (ProteinSimple) underpins competitive strength. In-house manufacturing control over most reagents reinforces quality and consistency across core categories.
Future-Ready Strategy: Focus on cell therapy, proteomic instrumentation, spatial biology, and precision diagnostics has expanded as a share of revenue and aligns with high-growth workflows. Acquisitions and strategic stakes (e.g., Lunaphore, Wilson Wolf/ScaleReady) position the portfolio for emerging demand.
At RefinedScience, we seamlessly integrate top-tier clinical and biological data with expert knowledge to provide unparalleled insights. We maximize patient impact with these unique insights by optimizing clinical trial probability of success and time to actionable results. We work across biopharma and we are a trusted partner in achieving better results, faster – working together to unlock strategic advantage
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development. We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to...
The SmartTab technology platform is a personalized wireless drug delivery solution comprised of an ingestible capsule with a microprocessor, smart polymer actuator, and active ingredients. SmartTab is focused on the development of three drug delivery systems: TargetTab™, InjectTab™ and MultiTab™. Providing novel effective therapies to improve patient outcomes and compliance.
We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—whether you’re a provider, drug developer, hospital, medical researcher or patient. That means everything from advancing diagnostic testing to helping launch new drugs, to offering new perspectives through data - all drawing from a deep...
Life sciences. Research. Precision manufacturing. If your life’s calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences. Our mission is to empower those seeking answers to life’s important scientific and healthcare questions. Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our...
Forge Biologics is a gene therapy contract development and manufacturing organization (CDMO) and clinical-stage therapeutics developer. The company helps scientists, physicians, biotechnology and pharmaceutical companies, and patient groups bring life-changing gene therapies from concept to patients. Its end-to-end capabilities include plasmid and AAV manufacturing, process and analytical development, cGMP production, fill and finish, and integrated regulatory support for transformative medicines...
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+...
The Sequencing Center, a next generation genome sequencing company, offers affordable genome sequencing, bioinformatics, and genome data management for research, pharmaceutical, and clinical organizations. Our services are designed for organizations performing research on bacterial, viral, and human-oriented projects.
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...
Smith & Nephew's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show mid-single-digit underlying growth through 2024–2025, with management reiterating guidance for continued growth in 2026. Early 2026 updates indicate broad-based contributions across units despite some subsegment variability.
Profitability: Trading profit and margins improved, supported by execution of the 12‑Point Plan and the transition to the RISE strategy. Management is guiding to further profit growth alongside higher returns.
Healthy Cash Flow: Free cash flow strengthened in 2025 with guidance for robust generation in 2026. Share repurchases completed and newly announced buybacks signal confidence and disciplined capital allocation.
Enrich is the leader in biotech and pharmaceutical portfolio management software, used in over half of the top 10 life sciences companies to value and manage portfolios of high risk, high investment assets. Our proprietary suite of tailored analytics and flexible on-demand visualizations are ideally suited for portfolio management.
































